This compound is primarily utilized in the development of pharmaceuticals, particularly in the synthesis of active pharmaceutical ingredients (APIs) targeting neurological disorders. Its structure, featuring a difluorophenyl group, makes it a valuable intermediate in the creation of molecules that interact with specific receptors in the brain, such as those involved in treating epilepsy or neurodegenerative diseases. Additionally, it serves as a chiral building block in asymmetric synthesis, enabling the production of enantiomerically pure drugs, which is crucial for enhancing efficacy and reducing side effects in therapeutic applications. Its role in medicinal chemistry underscores its importance in advancing treatments for complex health conditions.